Pure Global
NCT06308315

Effects of Rhythmic Balance Auditory Vision Training And Strength Training With Autism Spectrum Disorder.

Effects of Rhythmic Balance Auditory Vision Training And Strength Training On Motor Function And Cognition In Children With Autism Spectrum Disorder.
Riphah International University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Autism Spectrum Disorder
Drug/Device/Intervention
Rhythmic balance visual auditory exercise + Routine physical therapy
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Riphah International University
Location
Lahore, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Feb 25, 2024
End date
May 15, 2024
Enrollment
76 participants
Primary outcome

Bruininks-Oseretsky Test of Motor Proficiency (BOT-2)

Summary

Autism, a complex neurodevelopmental disorder that is marked by limited interests, and
 challenges in communication and social interactions and problem includes difficulties in
 understanding and responding to social cues, repetitive behaviors, intense focus on specific
 interests, and challenges with verbal and nonverbal communication. Rhythmic Balance Auditory
 Vision Training (RBAVT) a therapeutic approach which helps in improving coordination and
 balance in individuals with various neurological conditions. Strength training enhance
 physical health and muscle development. Thus, the purpose of this study is to compare the
 effects of rhythmic balance auditory vision training and strength training on motor function
 and cognition in children with autism spectrum disorder.

ICD-10 classifications
Childhood autismAtypical autismAsperger syndromeNeurotic disorder, unspecifiedMental and behavioural disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06308315
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06308315 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Autism Spectrum Disorder. Target enrollment is 76 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.